Categories
Change Password!
Reset Password!
Sublingual immunotherapy displays noteworthy effic...
Abrocitinib 100mg predicts week 12 success in atop...
Research in 'Dermatology and Therapy' aimed to predict the early efficacy of Abrocitinib in atopic dermatitis, suggesting potential for e...
Benralizumab: Promising results for eosinophilic a...
According to a recent post-hoc analysis of the ANANKE trial published in the Dovepress- Journal of Asthma and Allergy, the use of Benralizumab th...
Remineralizing roots: A study on toothpastes for a...
Innovative toothpastes with biomimetic and re-mineralising properties have been shown to have great potential against enamel demineralisation as...
Variations in chronic inducible urticaria: subtype...
CInducibleU is a kind of chronic urticaria (hives) triggered by specific factors. It can occur alone or alongside chronic spontaneous urticaria (...
Rapidly improved patient-reported outcomes with th...
The integrated data from the two clinical trials suggested that Upadacitinib monotherapy rapidly and effectively improved patient-reported outcom...
Omalizumab proves to be effective in treating food...
Food allergies, a growing concern with significant health impacts, currently have limited treatment options. A recent study in ‘The New Eng...
Chronic spontaneous urticaria revealed: Non-skin s...
The Journal of Allergy and Clinical Immunology's recent article investigated the prevalence of fever, joint pain, and malaise among chronic s...
Annual Allergen of the Year Award
To highlight allergens with significant clinical impact, bring awareness to under-recognized agents, and acknowledge those that have become outda...
20-year trajectory of risk and progression of poll...
Allergic rhinitis (AR) is a widespread chronic condition, but long-term data on its persistence and remission are scarce. This study explored the...
